Target intelligence / Profile preview

Transcription factor HES-1 (HES1) mRNA (HES1 mRNA)

Target
HES1 mRNA
Molecular classification
mRNA, Nucleic acid
01

Overview

HES1 mRNA is the transcript encoding the Hairy and enhancer of split-1 (HES1) protein, a basic helix-loop-helix (bHLH) transcription factor that functions as a key downstream effector of the Notch signaling pathway (UniProt P35428). HES1 primarily acts as a transcriptional repressor, regulating genes involved in cell fate determination, stem cell maintenance, and proliferation (PubMed: 25605871). In many cancers, HES1 is pathologically overexpressed, contributing to tumor progression, metastasis, and resistance to chemotherapy by maintaining a stem-like state in cancer cells (PubMed: 31235878). Because transcription factors like HES1 are traditionally difficult to target with small molecules, therapeutic strategies have shifted toward targeting the HES1 mRNA using antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs). These approaches aim to reduce HES1 protein levels by inducing the degradation of its mRNA or blocking its translation, thereby restoring normal cell differentiation and sensitizing tumors to treatment (PubMed: 28651318).

Other names
Hairy and enhancer of split-1 mRNAHES1 transcriptHairy-like protein 1 mRNAHHL mRNAHRY mRNA
02

Mechanism of action

Antisense-mediated mRNA degradation (RNase H-dependent) or RNA interference (RNAi) to prevent translation of the HES1 protein.

03

Biological functions

Transcription regulationNotch signaling pathwayCell differentiationCell proliferationNeurogenesisStem cell maintenance
04

Disease associations

CancerPancreatic cancerColorectal cancerLeukemiaGlioblastomaBiliary tract cancer
05

Safety considerations

Off-target effects of oligonucleotidesDisruption of normal Notch signaling in healthy tissues (e.g., gut toxicity)Innate immune activation by RNA-based drugs
06

Interacting drugs

Experimental HES1-targeting antisense oligonucleotides (e.g., HES1-ASO)

1 more in the full profile.

07

Biomarkers

HES1 mRNA expression levelsNotch pathway activation markersNotch intracellular domain (NICD) levels

Beyond the preview

Go deeper on Transcription factor HES-1 (HES1) mRNA (HES1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription factor HES-1 (HES1) mRNA (HES1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call